Bayer, J&J win third U.S. trial over Xarelto bleeding risk

(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding.